Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Conditions:   Advanced Solid Tumor;   MSI-H/dMMR Tumors;   Cutaneous Squamous Cell Carcinoma;   Urothelial Carcinoma;   Cervical Cancer;   HepatoCellular Carcinoma;   Esophageal Squamous Cell Carcinoma;   Merkel Cell Carcinoma;   Small-cell Lung Cancer;   Mesothelioma;   PD-L1 Ampli fied Tumor (9p24.1);   Nasopharyngeal Carcinoma Intervention:   Drug: INCB099280 Sponsor:   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials